Introduction

Chen-Si Lin currently works at the School of Veterinary Medicine, National Taiwan University. Their current project is 'The interaction between canine tumor and host immunity'. Finding the tumorigenesis, methods for diagnosing and​ treating canine cancers are the mainstream​ of their current study.

Disciplines

• Cancer Research
• Food Science
• Immunology

Skills and expertise

• Biological Tumor Markers
• Cancer Immunology
• Veterinary Clinical Pathology
• Flow Cytometry Analysis
• Veterinary Cancer therapy

Languages

• Chinese
• English

Our laboratory is dedicated to the intricate realms of disease surveillance, host immune responses, and the elucidation of disease mechanisms through cutting-edge next-generation sequencing analysis. With a comprehensive focus on these vital aspects, we are at the forefront of innovative research that contributes significantly to the advancement of medical science.

At the core of our endeavors lies disease monitoring, a fundamental facet that allows us to actively track and comprehend the prevalence, evolution, and dynamics of various diseases. Through meticulous surveillance methods, we gather crucial data that empower us to devise effective strategies for disease prevention, control, and management. By deciphering the intricate interplay between pathogens and hosts, we gain invaluable insights into disease progression, enabling us to devise targeted interventions and therapies.

Central to our laboratory's pursuits is the exploration of host immune responses. We delve into the intricate mechanisms by which the immune system recognizes and combats pathogens. This in-depth analysis not only enhances our understanding of immunology but also paves the way for the development of novel immunotherapies and vaccines. By unraveling the delicate dance between hosts and invaders, we contribute to the advancement of precision medicine and personalized treatment approaches.

In the era of rapidly evolving technologies, our laboratory harnesses the power of next-generation sequencing to unravel the complex tapestry of disease mechanisms and biological markers. Through state-of-the-art sequencing and analysis methods, we uncover genetic, epigenetic, and molecular signatures that underlie diseases. This knowledge not only deepens our comprehension of disease etiology but also holds the potential to revolutionize diagnostics and therapeutic interventions.

Our collaborative and interdisciplinary approach sets us apart. Our team comprises dedicated experts from diverse fields, including microbiology, immunology, genetics, and bioinformatics. This convergence of expertise fosters a holistic understanding of disease, enabling us to tackle complex research questions from multiple angles.

In essence, our laboratory stands as a hub of scientific inquiry, where the pursuit of knowledge intersects with the quest for improved healthcare outcomes. Through disease surveillance, host immune response exploration, and next-generation sequencing analysis, we contribute to the global effort to combat animal diseases and improve the well-being of individuals worldwide.